...Top 10 Pharmaceuticals in India, as of 2010[update] | Rank | Company | Revenue 2010 (Rs crore) | Revenue 2010 (Rs billion) | 1 | Ranbaxy Laboratories | 4,198.96 | 41.989 | 2 | Dr. Reddy's Laboratories | 4,162.25 | 41.622 | 3 | Cipla | 3,763.72 | 37.637 | 4 | Sun Pharmaceutical | 2,463.59 | 24.635 | 5 | Lupin Ltd | 2,215.52 | 22.155 | 6 | Aurobindo Pharma | 2,081.19 | 20.801 | 7 | GlaxoSmithKline | 1,773.41 | 17.734 | 8 | Cadila Healthcare | 1,613 | 16.13 | 9 | Aventis Pharma | 983.80 | 9.838 | 10 | Ipca Laboratories | 980.44 | 9.8044 | Major players [edit] Ranbaxy Laboratories Ranbaxy is the leader in the Indian pharmaceutical market, taking in $1.174 billion in revenues for a net profit of $160 million in 2004. It was the first Indian pharmaceutical to have a proprietary drug (extended-release ciprofloxacin, marketed by Bayer) approved by the U.S. FDA, and the U.S. market accounts for 36% of its sales. 78% of Ranbaxy’s sales are from overseas markets; its offices in 44 countries manage manufacturing in 7 countries and distribution in over 100. IMS Health estimated that Ranbaxy is among the top 100 pharmaceuticals in the world and that it is the 15th fastest growing company. By 2012, Ranbaxy hopes to be one of the top 5 generics producers in the world, and it consolidated its position with the purchase of French firm RGP Aventis in 2003. Ranbaxy also has higher aspirations, however, “to build a proprietary prescription business in the advanced markets...
Words: 1204 - Pages: 5
...TRANSFORMATIVE HR PRACTICES AT PIRAMAL GROUP- ALIGNMENT OF VALUES , HR PROCESSES AND EMPLOYEE ENGAGEMENT CHUNDURU SRINIVAS and MEENU BHATIA By MIRIYALA VENKATA SAIRAM MAYANK GOEL MIRZA ASGAR ALI About the Authors : Chunduru Srinivas : He has been with the Piramal Group for over a decade and is currently working as President – Human resources and Strategy . His areas of interest include new business opportunities ,M&A ,Investor relations ,Performance Management systems and Strategic planning. He is a regular speaker and has shared his views on skill building , challenges of learning organizations ,Employee engagement , Performance management system etc. Mentoring and teaching has been a passion and he has been addressing students since 13 years. He as been a speaker at prestigious management schools to name a few S.P.J.I.M.R , XLRI ,IIM – lucknow etc. He regularly mentors about 2500 MBA students yearly. Meenu Bhatia : She has been with piramal group since last three years and is currently managing the Learning and Development and Employee Engagement initiatives for the Piramal Group . She has spent more than 10 years in the HR domaon pursuing her passion in integrated development , content designing, Organizational development etc. Meenu is also a certified MBTI practitioner . She is also a core team member and an advisor to Umang foundations ,an NGO that works...
Words: 1104 - Pages: 5
...PHARMACEUTICAL INDUSTRY IN INDIA CURRENT SCENARIO India pharmaceutical industry * Tops the chart amongst India's science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. * Is the world’s third largest by volume. * Is a highly organized sector. * Estimated to be worth $ 4.5 billion,growing at about 8 to 9 percent annually. * Manufactures almost every type of medicine . * Is extremely fragmented with many registered units.(There are approximately 250 large units and about 8000 Small Scale Units) * Plays an important role in promoting and sustaining development in the field of global medicine. * Procures more than 50 % revenue coming from the overseas markets through exports MAJOR PLAYERS IN THE INDUSTRY Company | Market Share (%) | Total Pharma Market | 100.0 | Cipla | 5.3 | Ranbaxy | 5.0 | Glaxo Smithkline | 4.3 | Piramal Healthcare | 3.9 | Zydus Cadila | 3.6 | Source: ORG IMS | 1. Ranbaxy Laboratories Limited * Biggest pharmaceutical manufacturing company in India * Ranked at the 8th position among the global generic pharmaceutical companies * Has presence in 48 countries including world class manufacturing facilities in 10 countries 2. Dr. Reddy's Laboratory * Has 60 active pharmaceutical ingredients to manufacture drugs, critical care products, diagnostic kits and biotechnology products * The company has 6 FDA plants that produce...
Words: 1006 - Pages: 5
...A “Calibrated Approach”: Pharmaceutical FDI and the Evolution of Indian Patent Law Web version: August 2007 Authors: Katherine Connor Linton and Nicholas Corrado1 Abstract India has charted its own intellectual property (IP) path over the last 35 years, attempting to foster the growth of a domestic pharmaceutical industry and access to medicine while, more recently, also addressing the requirements of the international IP regime. Multinational companies (MNCs) have responded to India’s movement towards compliance with the W TO intellectual property agreement, TRIPS, by increasing the quantity and quality of foreign direct investment (FDI) in the areas of pharmaceutical research and development (R&D) and manufacturing. By contrast, MNCs have adopted a more cautious attitude toward the patenting and commercialization of new pharmaceutical products in India, waiting to see how Indian courts and patent offices interpret the new laws, and awaiting the enactment of longdebated data protection legislation. The ultimate success of the Indian “calibrated approach” to fostering the domestic industry and access to medicine while also addressing international IP requirements remains to be seen. 1 Katherine Connor Linton (katherine.linton@usitc.gov) is the International Trade Analyst for Intellectual Property and Nicholas Corrado was a law student intern in the Office of Industries of the U.S. International Trade Commission (USITC). The views expressed are those of Ms. Linton and...
Words: 6873 - Pages: 28
...45 46 47 48 49 50 51 52 53 54 55 56 57 Company Reliance Industries Limited Tata Consultancy Services (TCS) Infosys Technologies Ltd Wipro Limited Bharti Tele-Ventures Limited ITC Limited Hindustan Lever Limited ICICI Bank Limited Housing Development Finance Corp. Ltd. TATA Steel Limited Ranbaxy Laboratories Limited HDFC Bank Ltd Tata Motors Limited Larsen & Toubro Limited (L&T) Satyam Computer Services Ltd. Maruti Udyog Limited Bajaj Auto Ltd. HCL Technologies Ltd. Hero Honda Motors Limited Hindalco Industries Ltd Reliance Energy Limited Grasim Industries Limited Jet Airways (India) Ltd. Sun Pharmaceuticals Industries Ltd Cipla Ltd. Gujarat Ambuja Cements Ltd. Videsh Sanchar Nigam Limited The Tata Power Company Limited Sterlite Industries (India) Ltd. Associated Cement Companies Ltd. Nestlé India Ltd. Hindustan Zinc Limited GlaxoSmithKline Pharmaceuticals Limited Siemens India Ltd. Motor Industries Company Limited Mahindra & Mahindra Limited UTI Bank Ltd. Zee Telefilms Limited Bharat Forge Limited ABB Limited i-Flex Solutions Ltd. Dr. Reddy's Laboratories Ltd. Nicholas Piramal India Limited Kotak Mahindra Bank Limited Reliance Capital Ltd. Ultra Tech Cement Ltd. Patni Computer Systems Ltd. Wockhardt Limited Indian Petrochemicals Corporation Limited Biocon India Limited Essar Oil Limited. Asian Paints Ltd. Dabur India Limited Jaiprakash Associates Limited JSW Steel Limited Tata Chemicals Limited Tata Tea Limited 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78...
Words: 2235 - Pages: 9
...Accounting Standard 14 : Accounting for Amalgamations Organised by WIRC, Institute of Chartered Accountants of India Presented By Shri Rakesh Agarwal, Senior Manager, PricewaterhouseCoopers (India) Pvt. Limited Easy PDF Creator is professional software to create PDF. If you wish to remove this line, buy it now. licability & Scope of the Standard ndatory in nature for Accounting periods commencing o er 1-4-1995 ope Accounting for amalgamations and the treatment of any resultant goodwill or reserves. her Pronouncements General Clarification 4/2002 Accounting Standard Interpretation 11 Expert Advisory Opinion Easy PDF Creator is professional software to create PDF. If you wish to remove this line, buy it now. stions on Applicability & Scope of the Standa ions s the standard deals with cases where acquired company is not dissolved a arate entity continues to exist ? ere the purchase of 100 % in an company is not covered by the this standard n how it is accounted under Indian GAAP? at is the Situation where an accounting treatment is prescribed by Court Ord ere the financial statements which are going to be used by agencies like Wo de Organisations, Customs department, Income Tax department, etc., and th rtered accountant is asked to sign in his professional capacity, under such umstances what accounting principles can be adopted ? Is there any choice Paras 1, 2, of AS 14 and GC 4/2004, Industry Practice for Court ether with explanatory Notes) ...
Words: 2558 - Pages: 11
...differentiator for positioning it in the international markets SIP Project Report Submitted In Partial Fulfillment of Requirements for the PGDM Program 2010-12 Submitted by Name: Ashish Mohan Srivastava Roll number: 2010268 Supervisors: 1. Mr. Raj Kumar Verma Assistant Manager (Projects and Services) Moserbaer Photovoltaic India Ltd. 2. Professor J.Mohanty Institute Of Management Technology, Nagpur 2010-12 [pic] Acknowledgement It gives me a great sense of pleasure to present the report after undergoing an intense summer internship at Moserbaer’s Photo Voltaic wing. It is really difficult to gratify each and every person who has been instrumental in the completion of the project but I am taking great care that no one is left out. So in the same sequence at very first, I would like to acknowledge my parents because of whom I got the existence in the world for the inception and the conception of this project. Later on I would like to confer my acknowledgement to Mr. J.Mohanty my faculty guide and other faculty members who taught me how to do project through appropriate tools and techniques. Because Moserbaer India Ltd. has trusted me and given me a chance to do my integrated research study, I would like to give thanks to the organization and especially to Mr. Raj Kumar Verma (Asst. Manager, Projects and Services) my corporate mentor and Mr. Sanjeev Kumar (Research Scientist) from the depth of my heart. I would also like to thank Mr. Rakesh Singh (GM-...
Words: 5094 - Pages: 21
...INDIAN MARKET Due to poor sanitation conditions, infectious (acute) diseases are predominant in India. However, the incidence of chronic ailments, characterised by prolonged exposure, has been increasing with the emergence of lifestyle diseases in India, due to changing work pattern of the working population, higher stress levels, and unhealthy eating habits. Key issues answered through this analysis: What are acute and chronic ailments? What is the proportion of drugs for each segment in the total domestic formulations market? How have various therapeutic categories in the domestic formulation market performed over the last three years? Publish Date: 15-Jul-2013 | | Majority of ailments in India are more acute than chronic in nature Types of ailments Source: CRISIL Research Ailments can be classified into acute and chronic. Acute ailments are characterised by sudden, severe exposure (usually a single, large exposure) and rapid onset of the disease. The patient shows intense symptoms for a brief duration (not longer than 30 days). Infectious diseases such as common cold, fever, etc are some examples of acute ailments. However, some acute ailments may turn chronic if left unaddressed. Chronic ailments are characterised by prolonged or repeated exposures over many days, months or years. Chronic diseases can only be alleviated through treatments, but not fully cured. Unlike acute ailments, they do not usually resolve on their own accord. Examples of...
Words: 12248 - Pages: 49
...(FDA) approved facilities. US accounts for one-fourth of the Indian drug exports. The share of Indian pharma companies in the total approvals for generic drugs called Abbreviated New Drug Application (ANDA) has risen steadily. From 32 per cent in 2009, it went up to 38.5 per cent in 2013. Increasing share of Indian companies in total ANDAs approved by the USFDA can be attributed to increase spending by them for research and development (R&D) activities. As per CMIE’s database, the industry’s R&D expenses to sales ratio jumped to around five per cent in 2012-13 from around three per cent in 2003-04. The export of drugs from India is expected to grow by 4.2 per cent to USD 15.2 billion in 2013-14. Around USD 16.3 billion of drugs are likely to be shipped from the country in 2014-15. This translates into a growth of 7.3 per cent. In 2015-16, drug exports from India are expected to touch USD 17.5 billion, 7.7 per cent higher than the previous year. Many developing countries like Latin America and Africa have also opened doors for generic drugs due to ageing population, rising income levels, increasing lifestyle diseases and low penetration...
Words: 11886 - Pages: 48
...Business Quiz DHL Baseline/Tagline/AdLineof Company/Brands WE make importing Smooth Doordarshan Satyam Sivam Sundaram Electrolux India Makes life a little easier Energizer Keep going ESSAR Steel 24 carat steel Fed-Ex The World On Time Ford Mondeo Redefined Aggression Ford Motors Built for the road ahead Godrej locks PEACE OF MIND.GUARANTEED Graviera Suitings THE MAN OF SUBSTANCE Gucci Quality is remembered long after the price is forgotten Haier Inspired living Harley-Davidson If you don't have to answer to anyone, what would you do Harrod's retailer, ENTER A DIFFERENT London WORLD Hero Honda CBZ Motorcycling Unplugged Hero Honda Born in a studio, not in a Passion factory Hindustan Times Let there be light Hitachi Inspire the Next Honda The power of dreams Honda DIO FROM INDIA TO THE WORLD.AND TO YOU HSBC World's local bank Hughes Software Think skywards HYUNDAI Play a bigger game ELANTRA Hyundai's new ad Drive your way Jobsahead.com FILL IN YOUR AMBITION Johnnie Walker Keep Walking whiskey Kingfisher airlines Fly the good times Kodak You press the button and we do the rest Lacoste Because what you are LG EXPAND YOUR LIFE LG AC BREATHE HEALTHY Lufthansa There is no better way to 1 Created By: S.Sriram MBA-HR, TAMILNADU srirams@gmx.com Company Accenture Air Deccan Air India Air Sahara Airtel AKAI Allen Solly Allianz Insurance Apple Computers Bajaj Auto Bajaj Pulsar Bajaj spirit Blue Star BluestarAC Bournvita Brooke Bond BSNL BUSINESS STANDARD BUSINESSWORL Magazine of the...
Words: 24272 - Pages: 98
...A Handbook on Derivatives © Rajkumar .S Adukia B.com (Hons.), L.L.B, AICWA, FCA radukia@vsnl.com/rajkumar@gmail.com 093230 61049/ 093221 39642 www.carajkumarradukia.com If interested in receiving similar technical updates subscribe to carajkumarradukia-subscribe@yahoogroups.com PREFACE Derivatives have changed the world of finance as pervasively as the Internet has changed communications .Well they are everywhere nowadays. The most significant event in finance during the past decade has been the extraordinary development and expansion of financial derivatives. These instruments enhance the ability to differentiate risk and allocate it to those investors who are most able and willing to take it -- a process that has undoubtedly improved national productivity, growth and standards of living. Derivatives products provide certain important economic benefits such as risk management or redistribution of risk away from risk-averse investors towards those more willing and able to bear risk. Derivatives also help price discovery, i.e. the process of determining the price level for any asset based on supply and demand. All markets face various kinds of risks. This has induced the market par-ticipants to search for ways to manage risk. The derivatives are one ofthe categories of risk management tools. As this consciousness about risk management capacity of derivatives grew, the markets for derivatives...
Words: 15288 - Pages: 62
...8 10 12 14 16 22 24 41 55 85 106 147 183 231 This Annual Report is printed on 100% recycled paper as certified by the UK-based National Association of Paper Merchants (NAPM) and France - based Association des Producteurs et des Utilisateurs des papiers et cartons Recycles (APUR). Certain statements in this annual report concerning our future growth prospects are forward-looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in our earnings, revenue and profits, our ability to generate and manage growth, intense competition in IT services, our ability to maintain our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which we make strategic investments, withdrawal of fiscal governmental incentives,...
Words: 122508 - Pages: 491
...I L I T Y — C R E AT I N G A P O S I T I V E E C O N O M I C , S O C I A L A N D E N V I R O N M E N TA L I M PA C T CHAIRMAN’S LETTER 2009-10 has been a satisfactory year for your Company. Let me start with the financial results. Consolidated revenues for 2009-10 was Rs. 70,277 million. Excluding revenues from sumatriptan — your Company’s Authorized Generic version of Imitrex® which was launched in 2008-09 — revenue grew by 9%. In US dollar terms, 2009-10 revenue was US$ 1.56 billion. I am happy to inform you that the Company’s revenue has been rising at a CAGR of 23% over the last decade. That is a creditable performance by any standard. Your Company’s EBITDA of Rs. 15,828 million was the highest among pharmaceutical companies in India. Return on Capital Employed (RoCE) in 2009-10 was 17%, as against 14% in 2008-09. You may recollect that in my last year’s letter to you, I had...
Words: 111729 - Pages: 447
...sustained growth through foresight ANNUAL REPORT 2009-2010 Vision Global recognition for size, culture and quality, while nurturing nature and society. Mission Supporting the nation’s growth in power and steel with speed and innovation. Core Values l Crystal clear l Passion for excellence l Drive with leadership l Young thinking l Challenging status quo Contents Vice Chairman’s Statement.....................................02 Highlights 2009-10.....................................................04 Board of Directors........................................................05 Notice...............................................................................06 Directors’ Report..........................................................11 Management Discussion and Analysis......................22 Report on Corporate Governance...............................38 Auditors’ Report.................................................................48 Standalone Accounts.......................................................50 Consolidated Accounts...................................................79 Shri O. P. Jindal August 7, 1930 – March 31, 2005 O. P. Jindal Group – Founder and Visionary Only a life lived for others is a life lived worth while An industrialist par excellence under whose aegis the O P Jindal Group grew from strength to strength. But for the world at large Late Shri O P Jindal was much more than that. He was also a leader of masses, some one who...
Words: 76501 - Pages: 307
... awarding institution and date of the thesis must be given. Saurashtra University Theses Service http://etheses.saurashtrauniversity.edu repository@sauuni.ernet.in © The Author A STUDY OF CONSUMER BEHAVIOUR IN MALLS VIS-ÀVIS MOM-&-POP SHOPS A THESIS SUBMITTED TO SAURASHTRA UNIVERSITY FOR THE AWARD OF DEGREE OF Ph.D. IN MANAGEMENT SUBMITTED BY AJAY D. SHAH ASSISTANT PROFESSOR, MBA PROGRAM OSHWAL EDUCATION TRUST MANAGED SHRI JAYSUKHLAL VADHAR INSTITTUE OF MANAGEMENT STUDIES JAMNAGAR-361 004 UNDER THE GUIDANCE OF Dr. PRATAPSINH L. CHAUHAN DEAN – MANAGEMENT FACULTY DEPARTMENT OF BUSINESS MANAGEMENT (MBA PROGRAM) SAURASHTRA UNIVERSITY RAJKOT - 360 005 SEPTEMBER - 2009 CHAPTER – 1 OVERVIEW OF RETAIL INDUSTRY IN INDIA 1.1 1.2 Introduction Types of Retail Chain 1.2.1 1.2.2 1.2.3 1.2.4 1.2.5 1.2.6 1.3 1.4 Food & Beverage Retail Health & Beauty Retail Clothing & Footwear Retail Home Furniture & Household goods Retail Consumer durable Goods Retail Leisure & Personal Goods Retail Global Retail Industry Global Retail Chains 1.4.1 1.4.2 1.4.3 1.4.4 1.4.5 1.4.6 Wal-Mart Carrefour Tesco IKEA Metro...
Words: 77775 - Pages: 312
